'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances